1. World Health Organization. WHO Coronavirus (COVID-19)
Dashboard. https //covid19.who.int/ (accessed date: 19 April
2022).
2. Marin BG, Aghagoli G, Lavine K, et al. Predictors of COVID-19 severity: A literature review. Rev Med Virol 2021; 31:1-10.
3. Qi J, He D, Yang D, et al. Severity-associated markers and assessment model for predicting the severity of COVID-19: a retrospective study in Hangzhou, China. BMC Infect Dis 2021; 21: 774.
4. Hou H, Zhang B, Huang H, et al. Using IL-2R/lymphocytes for
predicting the clinical progression of patients with COVID-19.
Clin Exp Immunol 2020; 201: 76-84.
5. Smilowitz NR, Kunichoff D, Garshick M, et al. C-reactive protein
and clinical outcomes in patients with COVID-19. Eur Heart J
2021; 42: 2270-9.
6. Henry BM, de Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med 2020; 58: 1021-8.
7. Wang S, Sheng Y, Tu J, Zhang L. Association between peripheral lymphocyte count and the mortality risk of COVID-19 inpatients. BMC Pulm Med 2021; 21: 55.
8. Vardon-Bounes F, Gratacap MP , Groyer S, et al. Kinetics of mean platelet volume predicts mortality in patients with septic shock. PLoS One 2019; 14: e0223553.
9. Güçlü E, Kocayiğit H, Okan HD, et al. Effect of COVID-19 on platelet count and its indices. Rev Assoc Med Bras (1992) 2020; 66: 1122-7.
10. Vélez-Páez JL, Legua P , Vélez-Páez P , et al. Mean platelet volume and mean platelet volume to platelet count ratio as predictors of severity and mortality in sepsis. PLoS One 2022; 17: e0262356.
11. Zhang Z, Xu X, Ni H, Deng H. Platelet indices are novel predictors of hospital mortality in intensive care unit patients. J Crit Care 2014; 29: 885.
12. Liu Y , Sun W , Guo Y , et al. Association between platelet parameters and mortality in coronavirus disease 2019: Retrospective cohort study. Platelets 2020; 31: 490-6.
13. Larsen JB, Pasalic L, Hvas AM. Platelets in coronavirus disease
2019. Semin Thromb Hemost 2020; 46: 823-5.
14. Pujani M, Raychaudhuri S, Verma N, et al. Association of Hematologic biomarkers and their combinations with disease severity and mortality in COVID-19- an Indian perspective. Am J Blood Res 2021; 11: 180-90.
15. Ostadi Z, Shadvar K, Sanaie S, Mahmoodpoor A, Saghaleini SH: Thrombocytopenia in the intensive care unit. Pak J Med Sci 2019; 35: 282-7.
16. Shankaralingappa A, Tummidi S, Arun Babu T. Diagnostic value of platelet indices in COVID 19 infection: a case-control study from a single tertiary care center. Egypt J Intern Med 2022; 34: 35.
17. Golwala ZM, Shah H, Gupta N, Sreenivas V, Puliyel JM. Mean platelet volume (MPV), platelet distribution width (PDW), platelet count and plateletcrit (PCT) as predictors of in-hospital paediatric mortality: a case-control Study. Afr Health Sci 2016; 16: 356-62.
18. Mobarki AA, Dobie G, Saboor M, et al. MPR and NLR as prognostic markers in ICU-admitted patients with COVID-19 in Jazan, Saudi Arabia. Infect Drug Resist 2021; 14: 4859-64.
19. Yardımcı AC, Yıldız S, Ergen E, et al. Association between platelet
indices and the severity of the disease and mortality in patients
with COVID-19. Eur Rev Med Pharmacol Sci 2021; 25: 6731-40.
20. Shen Y, Huang X, Zhang W. Platelet-to-lymphocyte ratio as a prognostic predictor of mortality for sepsis: interaction effect with disease severity-a retrospective study. BMJ Open 2019; 9: e022896.
21. Damar Çakırca T, Torun A, Çakırca G, Portakal RD. Role of NLR, PLR, ELR and CLR in differentiating COVID-19 patients with and without pneumonia. Int J Clin Pract 2021; 75: e14781.
22. Sarkar S, Kannan S, Khanna P, Singh AK. Role of platelet-to-lymphocyte count ratio (PLR), as a prognostic indicator in COVID-19: a systematic review and meta-analysis. J Med Virol 2022; 94: 211-21.
23. Gao YD, Ding M, Dong X, et al. Risk factors for severe and critically ill COVID-19 patients: a review. Allergy 2021; 76: 428-55.
24. Wang J, Jiang M, Chen X, Montaner LJ. Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts. J Leukoc Biol 2020; 108: 17-41.
25. Han Q, Wen X, Wang L, et al. Role of hematological parameters in the diagnosis of influenza virus infection in patients with respiratory tract infection symptoms. J Clin Lab Anal 2020; 34: e23191.
26. Wang X, Li X, Shang Y, et al. Ratios of neutrophil-to-lymphocyte and platelet-to-lymphocyte predict all-cause mortality in inpatients with coronavirus disease 2019 (COVID-19): a retrospective cohort study in a single medical centre. Epidemiol Infect 2020; 148: e211.
27. Simadibrata DM, Calvin J, Wijaya AD, Ibrahim NAA. Neutrophil-to-lymphocyte ratio on admission to predict the severity and mortality of COVID-19 patients: A meta-analysis. Am J Emerg Med 2021; 42: 60-9.